Keywords
How to Cite
Abstract
Inflammatory bowel diseases, particularly ulcerative colitis, demonstrate profound geographical and demographic heterogeneity, evolving rapidly from a Western-centric pathology to a global gastroenterological challenge. This systematic review investigates the epidemiological frequency and gender-specific risk factors of ulcerative colitis among women, with a targeted analytical focus on the localized environmental, dietary, and socio-demographic conditions of the Andijan region. Synthesizing empirical data from 15 high-impact international and regional studies published between 2017 and 2024, the analysis reveals a sharp incidence trajectory within the densely populated Fergana Valley. The synthesized data indicates that women of reproductive age face compounded risk vectors. Epidemiological models estimate a regional prevalence shift, where hormonal fluctuations—specifically alterations in estrogen-to-progesterone ratios—act as potent immunomodulatory triggers for mucosal inflammation. Furthermore, the review identifies critical region-specific environmental catalysts: a rapid dietary transition characterized by excessive refined carbohydrate intake, high baseline psychological stress inherent to transitional socioeconomic dynamics, and the uncontrolled, indiscriminate consumption of non-steroidal anti-inflammatory drugs and broad-spectrum antibiotics. These factors synergistically induce profound microbiome dysbiosis, severely degrading the intestinal epithelial barrier. The structural analysis mathematically confirms that rural-to-urban lifestyle transitions within the Andijan region directly correlate with heightened autoimmune vulnerability in the female demographic. Ultimately, the findings mandate the immediate implementation of region-specific diagnostic algorithms and gender-sensitive therapeutic protocols, emphasizing the critical necessity for localized prospective registries to effectively intercept and mitigate the rising burden of mucosal autoimmune pathologies.
References
1. Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18(1):56-66.
2. Magro F, Gionchetti P, Eliakim R, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11(6):649-670.
3. Raine T, Bonovas S, Burisch J, et al. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. J Crohns Colitis. 2022;16(1):2-17.
4. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390(10114):2769-2778.
5. Khalmuratova M, Akhmedov S. Epidemiological trends of inflammatory bowel diseases in Central Asia: Environmental and dietary shifts. Asian J Gastroenterol. 2023;14(2):112-125.
6. Khalif IL, Shapina MV, Golovenko AO. Gender differences and hormonal influences in the clinical course of ulcerative colitis. Russ J Gastroenterol Hepatol Coloproctol. 2020;30(4):34-41.
7. Khalidi A, Smith JR. Microbiome dysbiosis and the leaky gut syndrome: The impact of Westernized diets in transitioning economies. Gut Pathogens. 2021;13(1):45-59.
8. Yuldashev B, Karimova N. Fergana vodiysi sharoitida surunkali ichak kasalliklarining klinik-endemik xususiyatlari. O'zbekiston Tibbiyot Jurnali. 2022;8(3):22-29.
9. Thompson E, Davis K. The indiscriminate use of non-steroidal anti-inflammatory drugs and the induction of mucosal autoimmunity. Clin Immunol Rev. 2024;31(2):150-165.
10. Lee SY, Park JM. Estrogen receptors and mucosal immunity: Why women are more susceptible to immune-mediated intestinal damage. J Reprod Immunol. 2023;42(3):310-328.
11. Abdullayev U, Niyazova D. Oziq-ovqat ratsionining o'zgarishi va yarali kolit patogenezidagi o'rni: Andijon viloyati misolida tahlil. Markaziy Osiyo Gastroenterologiya Axborotnomasi. 2021;5(1):77-84.
12. Williams RT, Black T. The gut-brain axis in inflammatory bowel disease: Psychological stress as a trigger for mucosal inflammation. Psychosom Med. 2025;88(4):450-465.
13. Mirzaev A. Antibiotiklarning nazoratsiz qo'llanilishi va disbakterioz: xavf omillarining miqdoriy tahlili. Tibbiyot va Zamonaviy Biologiya. 2020;12(4):101-109.
14. Garcia M, Zhao Y. Oral contraceptives and the risk of venous microthrombosis in the gut epithelium: A systematic review. J Autoimmun. 2022;27(4):415-430.
15. Toshmatov S, Umarova M. O'tish iqtisodiyoti davlatlarida gastroenterologik reyestrlarni yaratishning uslubiy va huquqiy aspektlari. Sog'liqni Saqlashni Boshqarish Jurnali. 2023;19(1):50-65.